Thrombolysis of Urokinase for Minor Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

1,005

Participants

Timeline

Start Date

October 4, 2020

Primary Completion Date

February 18, 2023

Study Completion Date

February 18, 2023

Conditions
Minor Stroke
Interventions
DRUG

Urokinase thrombolysis

The patients of intervention group will receive 1 millions units urokinase dissolved by 100 saline through intravenous infusion within 30 minutes.

DRUG

Aspirin;Clopidogrel

The control group will receive antiplatelet agents as decided by the physicians according to Chinese guideline for diagnosis and treatment of acute ischemic stroke 2018.

Trial Locations (1)

0371

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
collaborator

Beijing Tiantan Hospital

OTHER

collaborator

Shanghai 10th People's Hospital

OTHER

collaborator

General Hospital of Shenyang Military Region

OTHER

lead

The First Affiliated Hospital of Zhengzhou University

OTHER

NCT04420351 - Thrombolysis of Urokinase for Minor Stroke | Biotech Hunter | Biotech Hunter